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Abstract
Objectives This study aims to evaluate the effect of adding
bone substitute materials (BSM) to particulated autogenous
bone (PAB) on the volume fraction (Vf) of newly formed
bone after maxillary sinus augmentation.
Materials and methods Thirty healthy patients undergoing
maxillary sinus augmentation were included. PAB (N010),
mixtures of PAB and beta-tricalciumphosphate (PAB/β-TCP)
(N010), as well as PAB and β-TCP and hydroxyapatite
(PAB/HA/β-TCP) (N010) were randomly used for sinus
augmentation. A sample of the graft material was main-
tained from each patient at time of maxillary sinus aug-
mentation, and Vfs of the PAB and/or BSM in the
samples were determined by means of microcomputerized
tomography (μ-CT). Five months later, samples of the
grafted areas were harvested during implantation using a
trephine bur. μ-CT analysis of these samples was per-
formed, and the Vf of bone and BSM were compared
with the data obtained 5 months earlier from the original
material.
Results The mean Vf of the bone showed a statistically sig-
nificant increase (p<0.05) in all groups after a healing period
of 5 months without statistically significant difference be-
tween the groups.
Conclusions With regard to the increase of bone volume,
it is not relevant if PAB is used alone or combined with
β-TCP or HA/β-TCP.
Clinical relevance The amount of PAB and associated donor
site morbidity may be reduced by adding BSM for maxillary
sinus augmentation.
Keywords Maxillary sinus augmentation .Bone . Substitute
materials
Introduction
The severely atrophic posterior maxilla can successfully be
treated by maxillary sinus augmentation as described by
Boyne and James or Tatum [1–6] prior to implant place-
ment. Though many studies have documented the suitability
of different materials for maxillary sinus augmentation, such
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as autogenous bone, biomaterials, or combinations of both
[7–13], it still remains widely unknown which material is
the most favorable [14–16].
Regardless of the material used for augmentation, the
structure of the graft after healing must provide a micro-
architecture that allows a sufficient implant anchorage
through osseointegration. The mechanical stability of
osseointegrated implants is dependent on the quality
and quantity of the adjacent bone and its biomechanical
properties. Therefore, obtaining a maximum of bone
quantity is one of the key goals in augmentative implant
surgery.
Many studies have evaluated the amount of newly
formed bone following maxillary sinus augmentation with
different grafting materials in histological sections of sam-
ples retrieved several months after lateral antrostomy [14,
17–22]. Though autogenous bone is still regarded as stan-
dard for grafting [23, 24], it could be shown that a remarkable
amount of newly formed bone is obtainable when substitute
materials are used alone [18, 25]. Since it is well known that
autogenous bone has osteoinductive properties [26, 27], the
question arises as to whether mixtures of bone and BSM result
in a similar amount of newly formed bone when used for
maxillary sinus augmentation as for autogenous bone alone.
When adding autogenous bone to substitute materials for
maxillary sinus augmentation, the correct determination of
the amount of newly formed bone in histological samples
presents a challenge because the volumetric distribution and
amount of bone and substitute material at the time of maxil-
lary sinus augmentation is unknown. μ-CTwas successfully
used to visualize and evaluate the volumetric distribution of
bone and substitute materials in bony samples retrieved after
maxillary sinus augmentation [28]. As a non-invasive tech-
nique, μ-CTmight also be suitable to evaluate the volumetric
distribution of bone and BSM in a particulated form, e.g., the
particulated graft at the time of maxillary sinus augmenta-
tion. Comparing the volumetric distributions of bone and
BSM at the time of sinus augmentation with the volumetric
distributions in samples retrieved several months after
healing has not been performed until now. This allows
the determination of changes in the volumes of bone and
substitute material over time. The working hypothesis is
that adding BSM to PAB results in a smaller amount of
newly formed bone volume 5 months after maxillary
sinus augmentation when compared to the use of PAB
alone.
Materials and methods
The study protocol was approved by the ethics committee of
the Johannes Gutenberg University of Mainz (No. 837.158.08
(6155)).
Patients
Thirty consecutive, systemically healthy patients (17 female,
13 male; mean age 54; range 36–79) who presented for
maxillary sinus augmentation were included in this study.
Informed consent was obtained from all patients prior
participation in this study. Exclusion criteria were ad-
vanced systemic diseases, osteoporosis, pregnancy, infec-
tious diseases, radiation, corticosteroid and bisphosphonate
medication, chemotherapy, and smoking.
Before surgical treatment, patients were randomly enrolled
in one of the following treatment groups:
Group A: Mixture of blood, particulated autogenous bone
(PAB), and β-TCP (N010).
Group B: Mixture of blood, PAB, and β-TCP/HA (N010).
Group C: Mixture of blood and PAB (N010).
Surgical procedure
A mucoperiosteal flap was elevated and access to the sinus
membrane was achieved by drilling an oval hollow into the
facial sinus wall with a diamond bur. The bone in the center of
the drilled window was gently infractured and the intact
Schneiderian membrane was elevated. Once the Schneiderian
membrane was completely mobilized, the infractured bone
was folded inwards and upwards, imitating a trapdoor effect.
Autogenous bone was harvested as a block either from
the chin or the linea obliqua externa and particulated using a
surgical bone mill (Quetin bone mill®, Quetin Dental
Products, Leimen, Germany). The particulated bone was
mixed with blood, and BSM was added in a ratio of
approximately 1:1. β-TCP (Cerasorb® 1,000–2,000 μm,
Curasan AG, Kleinostheim, Germany) was used in
group A (N010) and a β-TCP/HA mixture (Straumann®
BoneCeramic 500–1,000 μm; Institut Straumann AG,
Basel, Switzerland) in group B (N010). In group C
(N010), only PAB and blood were used without any
additional BSM.
A sample of approximately 0.5 cm3 of each particulated
graft was collected at the time of sinus augmentation and
maintained in a standard polypropylene snap-lock tube
(Eppendorf Safe-Lock Tubes® 0.5 ml, Eppendorf AG,
Hamburg, Germany). For plugging the graft into the tubes,
the same forces as for the maxillary sinus augmentation
were applied as far as possible. They were plugged by
one of the two oral surgeons (S.K. and M.K) with more
than 10 years of professional experience who performed
the maxillary sinus augmentations. The samples were fixed
with buffered, paraformaldehyde fixative solution (Roti
Histofix® 4.5 %; Carl Roth GmbH + Co KG, Karlsruhe,
Germany), and μ-CT of the filled snap-lock tubes was
performed.
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Bony cylinders were harvested from the grafted areas
during implant placement 5 months after maxillary sinus
augmentation by means of a trephine bur with an internal
diameter of 3.2 mm (Fig. 1). The cylinders were gently
removed from the trephine and immediately immersed in
4.5 % buffered, pH 7.0 paraformaldehyde fixative (Roti
Histofix 4.5 %; Carl Roth GmbH + Co KG, Karlsruhe,
Germany) for at least 7 days. After dehydrating in alcohol
in ascending ethanol series, the cylinders were embedded in
paraffin according to standard protocols (Hypercenter XP,
Shandon, Frankfurt am Main, Germany) and a μ-CT exami-
nation was performed.
A total of 46 samples were evaluated (23 samples of
the particulated graft maintained at time of sinus aug-
mentation and 23 bony samples retrieved 5 months after
healing). Seven patients were consecutively excluded
from the study: one of group A, two of group B, and
two of group C because of insufficient sample retrieval
at re-entry. Two patients were additionally excluded
from group C because of steroid medication after max-
illary sinus augmentation.
μ-CT
All analyses were carried out using a high-resolution μ-CT
with a nominal isotropic resolution of 6×6×6 μm3 voxelsize
(SCANCO® μ-CT 40, SCANCO Medical AG, Brüttisellen,
Switzerland) at identical settings (70 kV, 113 μA, 0.18° an-
gular increment, 300 ms integration time).
Each polypropylene snap-lock tube containing the par-
ticulated bone or bone and substitute material was clamped
into a specimen holder of the μ-CT for examination.
The paraffin-embedded samples retrieved 5 months later
were placed into conical pipette tips (100 μl MBP Pipet Tips
No. 3550, Molecular Bioproducts, Inc., USA), such that the
tips held the samples through an interference fit. The pipette
was then fixed in a specimen holder of the μ-CT for exam-
ination avoiding movements.
Three-dimensional reconstructions of the μ-CT data
were performed (Figs. 2 and 3) based on thresholds for
bone and substitute material according to histogram
distribution of grey values described in a previous study
of Kühl et al. [28]. The thresholds for bone were set at
280–550 mgHA/cm3 (representing the intermediate-
density material) and at 550–1,000 mgHA/cm3 (repre-
senting high-density material) for the BSM. Following
the segmentation process, a morphological filter opera-
tion by means of dilatation and erosion in the border
zones of the substitute materials was applied prior to the
evaluation with the SCANCO imaging software in order
to reduce artefacts. For volume analysis, a volume of
interest was first determined, in which the alveolar bone
was not included. Based on the segmentation process,
the volume of bone (Vb) and the volume of BSM
(Vsm) were separately evaluated within the volume of
interest. Percentage distribution of bone (Vfb) and BSM
(Vfsm) were calculated as volume fractions by dividing
Vb or Vsm by the volume of interest.
Statistical analyses
The mean percentage volume fraction of bone (Vfb) and
BSM (Vfsm), including standard deviation (SD), were
calculated for each group at the time of maxillary sinus
augmentation and again 5 months later. An analysis of
variance was performed to evaluate statistically signifi-
cant differences between the individual groups with
regard to the changes of Vfb and Vfsm between the
two points in time (at time of maxillary sinus augmen-
tation and 5 months later) and between each group.
Significance was considered to be p<0.05. The statisti-
cal analyses were performed with a statistics package
(SPSS).
Results
The Vfsm decreased in both groups 5 months after sinus
augmentation (Table 1) from a mean Vfsm of 8.9 % to
5.1 % in group A and from 10.1 % to 5.0 % in group
B (Fig. 4). Based on the data obtained, a power analysis
was performed showing a level of <80 % for both
groups.
In contrast to this, the Vfb showed a statistically signif-
icant increase 5 months after maxillary sinus augmentation
in all groups (Table 2), whereas the Vfb increased by a mean
of 17.1 % in group A, by a mean of 21.7 % in group B, and
by 18.5 % in group C (Fig. 5). The increase of bone between
the groups showed no statistically significant differences at
p>0.05 (Table 2). The power analysis showed a level of
significance >80 %.
Fig. 1 Five months after maxillary sinus augmentation, samples of the
augmented areas were retrieved by means of a trephine bur and
embedded in paraffine before μ-CT analyses
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Discussion
The volume distribution of bone, the bone density, and the
bone stability stand in close relationship one to another.
BSM has no mechanical stability in its particulated form.
To gain biomechanical stability, it has to be surrounded by
bone: the greater the bone volume, the higher the strength
will be. The volume of newly formed bone is therefore an
important aspect in comparing different grafting materials.
Beside volume, the bone quality plays a key role in biome-
chanical stability. The bone quality is generally determined
by evaluating the bone's density. Bone stability grows with
increasing density. Taking this into account, it is of special
clinical interest to evaluate both volume and density of the
bone obtained after grafting with different materials. The
current investigation using μ-CT revealed a statistically
Fig. 2 3D reconstructions after segmentation of the μ-CT data for a
sample maintained at the time of maxillary sinus augmentation of
group A (upper row) B (middle row), and C (lower row). The bone
is green and the BSM particles are gray. The left image shows the
structure of the grafts' total volume at the time of maxillary sinus
augmentation; the middle and right images, respectively, show longi-
tudinal and cross-sectional slices through the particulated grafts
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significant increase in the percentage of bone 5 months after
maxillary sinus augmentation for three different grafting
materials. Autogenous bone is regarded as standard for
grafting procedures because of its osteoinductive properties
[23, 26, 27]. It was therefore expected that the amount of
newly formed bone might be negatively affected by adding
bone substitute material particles providing osteoconductive
properties only. Frenken et al. [25] used a mixture of HA/β-
TCP (Straumann® Bone Ceramic) without adding autoge-
nous bone for maxillary sinus augmentation. After an
Fig. 3 3D reconstructions after
segmentation of the μ-CT data
of a sample of group A (upper
row), group B (middle row),
and C (lower row) retrieved
5 months after maxillary sinus
augmentation. The bone is
green and the BSM is gray. The
volume of the bone and the
BSM were calculated according
to the segmentation
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average healing time of 6 months, the ratio bone volume to
total volume was measured to be 27.3 % in histological
samples. As no autogenous bone was used in this study,
the newly formed bone represents the effective bone volume
increase 6 months after maxillary sinus augmentation. In
contrast to this, Cordaro et al. [18], in a similar study, found
a rate of newly formed bone of 19.8 % with the same HA/β-
TCP (Straumann Bone Ceramic®) substitute material. As it
is known that autogenous bone has osteoinductive proper-
ties, the combination of autogenous bone and substitute
materials was expected to be beneficial with regard to the
obtained volume of newly formed bone in our study. In our
study, however, the effective volume of newly formed bone
—i.e., the difference between the bone volume within the
grafts at the time of sinuslift procedure and the samples
retrieved 5 months later—was measured to be 21.7 %. This
indicates a lower bone formation rate than in the study
published by Frenken et al. and a slightly higher value than
in the study of Cordaro et al. [18, 25]. The reason for this
discrepancy might be related to the different mean healing
time of approximately 4 weeks between the studies with the
shortest healing times for the study of Cordaro et al. [18].
Artzi et al. [29] found that the percentage amount of newly
formed bone increases over an extended healing period. In
their study, autogenous bone and HA/β-TCP were mixed at
a ratio of 1:1, and bony samples were retrieved 6 and
9 months after grafting the maxillary sinus. The amount of
newly formed bone increased from 28.6 % after 6 months to
41.6 % after an average healing time of 9 months. Based on
these observations, it can be assumed that the measured Vfb
in our study would also have been higher than 24.8 % with a
longer healing period.
The bone volume ingrowth of 17.1 % for group A (β-TCP,
Cerasorb®) was the smallest, resulting in a Vfb of 21.4 %.
Artzi et al. [19] used a mixture of β-TCP (Cerasorb®) and
autogenous bone in a clinical study for maxillary sinus aug-
mentation and found an average bone area fraction of 32 %
after a healing time of 12 months. This difference to our study
may also be related to the longer healing time.
Suba et al. [22] performed a study on bilateral sinuslift,
using autogenous particulated bone on one side and β-TCP
(Cerasorb®) on the other. In contrast to the above findings,
the trabecular bone volume was 32.4 % for the experimental
side (Cerasorb®) and 34.7 % for the control sides in samples
retrieved 6 months after sinus augmentation. As observed in
Table 1 Percentage volume of bone substitute materials (Vfsm) for both
groups: A 0 autogenous bone + β-TCP and B 0 autogenous bone + β-
TCP/HA at different stages (t00at time of maxillary sinus augmentation;
t105 months after maxillary sinus augmentation) (number of samples
(N), minimum, maximum, mean and standard deviation (SD))
Vfsm (%)
Groups N Min. Max. Mean SD
A t0 9 2.2 17.7 8.9 5.4
t5 9 0.1 16.5 5.1 5.9
B t0 8 6.5 15.3 10.1 3.2
t5 8 0.7 13.3 5.0 4.1
Fig. 4 Mean differences
between Vfsm at time of
maxillary sinus augmentation
and 5 months later for group A
(left boxplot) and group B
(right boxplot). The differences
between the two groups
(A and B) were not statistically
significant (p00.728)
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our study, the bone volume ingrowth was smaller for the β-
TCP group than for the control group with autogenous bone
alone.
In comparison to groups A and B, the bone ingrowth
in group C (autogenous bone alone) was measured to be
18.5 %, resulting in a bone Vfb of 25.53 %, which
represents the highest bone volume to total volume value
of the three groups. The higher amount of bone volume
might be explained by the higher Vfb of 7.0 % at the
time of maxillary sinuslift in comparison to group A
(4.3 %) and group B (3.1 %). Taking this into consider-
ation, the effective bone volume ingrowth of 18.5 %
ranges between the effective bone ingrowth of groups
A (17.1 %) and B (21.7 %).
The data revealed that there is no statistically significant
difference in Vf in any of the groups. The reason for the
same ingrowth in all groups cannot be determined by this
study. Obviously in the present clinical setup, BSM showed
sufficient osteogenic potential to support similar bone in-
growth as seen in controls. In agreement with data from
other studies, our findings seem to support clinical applica-
tion of BSM for sinus grafting procedures. Additionally,
BSM have shown less tendency for resorption in clinical
long-term applications compared to autogenous bone grafts
and may potentially be beneficial with regard to donor site,
harvest morbidity, and patients' acceptance.
Our data indicate that using mixtures of autogenous bone
and β-TCP or mixtures of PAB and HA/β-TCP as well as
Table 2 Percentage volume of bone (Vfb) for all groups: A 0 autog-
enous bone + β-TCP, B 0 autogenous bone + β-TCP/HA and C 0
autogenous bone at different stages (t00at time of maxillary sinus
augmentation; t105 months after maxillary sinus augmentation) (num-
ber of samples (N), minimum, maximum, mean and standard deviation
(SD))
Vfb (%)
Groups N Min. Max. Mean SD p Diff. Vfb (%) p (Diff. Vfb)
A t0 9 2.4 6.3 4.3 1.2 0.01 17.1 0.578
t5 9 4.5 34.3 21.4 9.0
B t0 8 1.6 7.0 3.1 1.8 0.01 21.7
t5 8 16.2 42.0 24.8 10.2
C t0 6 3.1 13.1 7.0 3.4 0.03 18.5
t5 6 15.9 31.6 25.5 5.7
P values indicate statistical significance with p<0.05 within each group between t0 and t1. Diff. Vfb represents the mean difference of bone volume
between t0 and t1. P value for diff. Vfb indicates no statistically significant differences between the groups
Fig. 5 Mean differences
between Vfb at time of
maxillary sinus augmentation
and 5 months later for group A
(left boxplot), group B
(middle boxplot), and group C
(right boxplot). There was no
statistically significant
difference in bone increase
between the three groups
(p00.578). Outlayer appeared
only in group A and B with
more than 30 % of newly
formed bone in group C and a
negative difference in on case
of group B due to bony
resorption
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PAB alone for maxillary sinuslift procedure result in a
remarkable amount of newly formed bone after a healing
time of 5 months. Differences between the investigated
materials are negligible, and it can be assumed that these
differences are of limited clinical importance. However, the
volume of newly formed bone in our study was not nega-
tively affected by adding BSM to autogenous bone. Adding
BSM to PAB may reduce donor site morbidity since less
autogenous material is needed. This is of clinical relevance
in cases with severe atrophy of the jaws.
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